Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Silent mutations result in HlyA hypersecretion by reducing intracellular HlyA protein aggregates

View through CrossRef
AbstractEscherichia coli is one of the most widely used hosts for the production of recombinant proteins. Extracellular protein secretion has the advantage of reducing protein aggregation and simplifying downstream purification. The introduction of five rare codons in a specific region of the α‐hemolysin (hlyA) gene previously was shown to result in eightfold improvement in secretion of HlyA via the hemolysin (Type‐I) pathway. Here we investigate the biological basis for the observed phenomenon that translation rate of HlyA protein may be related to the ability to secrete higher levels of HlyA via the Type‐I pathway. A detailed comparative analysis between a hypersecreter mutant strain (hly‐slow) and a control strain (hly‐parent) shows a significant decrease (by ∼50%) in the intracellular level of HlyA protein in the hly‐slow strain relative to the hly‐parent strain. Nearly 100% of the intracellular HlyA protein exists in the inclusion body fraction in both the strains. These results demonstrate the importance of synonymous codon changes in the context of improving HlyA secretion yield via Type‐I pathway and further illustrate that production of high levels of secreted proteins appears to require a balance between translation and secretion rate. Biotechnol. Bioeng. © 2008 Wiley Periodicals, Inc.
Title: Silent mutations result in HlyA hypersecretion by reducing intracellular HlyA protein aggregates
Description:
AbstractEscherichia coli is one of the most widely used hosts for the production of recombinant proteins.
Extracellular protein secretion has the advantage of reducing protein aggregation and simplifying downstream purification.
The introduction of five rare codons in a specific region of the α‐hemolysin (hlyA) gene previously was shown to result in eightfold improvement in secretion of HlyA via the hemolysin (Type‐I) pathway.
Here we investigate the biological basis for the observed phenomenon that translation rate of HlyA protein may be related to the ability to secrete higher levels of HlyA via the Type‐I pathway.
A detailed comparative analysis between a hypersecreter mutant strain (hly‐slow) and a control strain (hly‐parent) shows a significant decrease (by ∼50%) in the intracellular level of HlyA protein in the hly‐slow strain relative to the hly‐parent strain.
Nearly 100% of the intracellular HlyA protein exists in the inclusion body fraction in both the strains.
These results demonstrate the importance of synonymous codon changes in the context of improving HlyA secretion yield via Type‐I pathway and further illustrate that production of high levels of secreted proteins appears to require a balance between translation and secretion rate.
Biotechnol.
Bioeng.
© 2008 Wiley Periodicals, Inc.

Related Results

7 th International Symposium on Enabling Technologies for Life Sciences (ETP)
7 th International Symposium on Enabling Technologies for Life Sciences (ETP)
The seventh in the series of ETP Symposia (see Rapid Communications in Mass Spectrometry 2012, 26 , ...
Analysis of the in vivo activation of hemolysin (HlyA) from Escherichia coli
Analysis of the in vivo activation of hemolysin (HlyA) from Escherichia coli
Hemolysin (HlyA) from Escherichia coli containing the hlyCABD operon separated from the nonhemolytic pro-HlyA upon two-dimensional (2-D) polyacrylamide gel electrophoresis. The mig...
Prelytic and lytic conformations of erythrocyte-associated Escherichia coli hemolysin
Prelytic and lytic conformations of erythrocyte-associated Escherichia coli hemolysin
Flow cytometry was developed as a method to assess the conformation of erythrocyte-bound Escherichia coli hemolysin polypeptide (HlyA). Topology of membrane-associated hemolysin (H...
Endothelial Protein C Receptor
Endothelial Protein C Receptor
IntroductionThe protein C anticoagulant pathway plays a critical role in the negative regulation of the blood clotting response. The pathway is triggered by thrombin, which allows ...
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Abstract Background: Imetelstat, a first in class specific telomerase inhibitor, induced hematologic responses in all patients (pts) with essential thrombocythemia (...

Back to Top